BioCatalystWatch
MBRXWorkspace / MBRX / OverviewCompany library
Moleculin Biotech, Inc. logo

Moleculin Biotech, Inc.

Moleculin Biotech, Inc. (MBRX)

Website

Price
Market cap
Next catalystDec 12-15, 2026Annamycin + cytarabine — MIRACLE (MB-108) · Phase 2/3 dataCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

AnnamycinAnnamycin + cytarabine — MIRACLE (MB-108)

Topoisomerase IIα/β

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

AnnamycinAnnamycin + cytarabine — MIRACLE (MB-108)

Topoisomerase IIα/β

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Other pipelines

Annamycin

Topoisomerase IIα/β

PreINDP1P2FilingApproved
Upcoming / outlook

Annamycin

Topoisomerase IIα/β

PreINDP1P2FilingApproved
Upcoming / outlook

Annamycin

Topoisomerase IIα/β

PreINDP1P3FilingApproved
Upcoming / outlook

WP1066

STAT3 / p-STAT3 × c-Myc × HIF-1α

WP1066

STAT3 / p-STAT3 × c-Myc × HIF-1α

PreINDP1P2P3FilingApproved
Upcoming / outlook

History / paused

Annamycin

Topoisomerase IIα/β

PreINDP1P2P3FilingApproved
Annamycin

Topoisomerase IIα/β

PreINDP1P2P3FilingApproved
Annamycin

Topoisomerase IIα/β

PreINDP1P2P3FilingApproved
Annamycin

Topoisomerase IIα/β

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

MBRX PR & News

PR & News

MBRX SEC archive